BlackRock Health Sciences Trust II

Company Profile

BlackRock Health Sciences Trust II had its IPO on 2020-01-29 under the ticker symbol BMEZ.

The company operates in the sector and industry. BlackRock Health Sciences Trust II has a staff strength of 0 employees.

Stock update

Shares of BlackRock Health Sciences Trust II opened at $14.72 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $14.59 - $14.93, and closed at $14.87.

This is a -0.8% slip from the previous day's closing price.

A total volume of 1,014,223 shares were traded at the close of the day’s session.

In the last one week, shares of BlackRock Health Sciences Trust II have slipped by -5.04%.

BlackRock Health Sciences Trust II's Key Ratios

BlackRock Health Sciences Trust II has a market cap of $1.78 billion, indicating a price to book ratio of 0.8456 and a price to sales ratio of 2.4163.

In the last 12-months BlackRock Health Sciences Trust II’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures BlackRock Health Sciences Trust II's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BlackRock Health Sciences Trust II’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, BlackRock Health Sciences Trust II’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BlackRock Health Sciences Trust II’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-6.07 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BlackRock Health Sciences Trust II’s profitability.

BlackRock Health Sciences Trust II stock is trading at a EV to sales ratio of 7.3758 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 2.4163.

BlackRock Health Sciences Trust II stock pays annual dividends of $0 per share, indicating a yield of 10.71% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$3.45 billion

Total Liabilities

$0

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

BlackRock Health Sciences Trust II ended 2024 with $3.45 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.45 billion while shareholder equity stood at $3.36 billion.

BlackRock Health Sciences Trust II ended 2024 with $0 in deferred long-term liabilities, $0 in other current liabilities, in common stock, $1.85 billion in retained earnings and $0 in goodwill. Its cash balance stood at $0.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

BlackRock Health Sciences Trust II’s total current assets stands at $0 while long-term investments were $3.42 billion and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $20.26 million and inventory worth $0.

In 2024, BlackRock Health Sciences Trust II's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, BlackRock Health Sciences Trust II paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$14.87

52-Week High

$16.6538

52-Week Low

$13.3964

Analyst Target Price

$

BlackRock Health Sciences Trust II stock is currently trading at $14.87 per share. It touched a 52-week high of $16.6538 and a 52-week low of $16.6538. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $15.8 and 200-day moving average was $15.47 The short ratio stood at 0.61 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 2553% are held by institutions.